Group One Trading
AGIO icon

Group One Trading’s Agios Pharmaceuticals AGIO Stock Holding History

Group One Trading’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.25M Sell
66,500
-182,700
-73% -$5.18M ﹤0.01% 1963
2025
Q4 		$6.78M Buy
249,200
+234,400
+1,584% +$8.22M 0.01% 1238
2025
Q3 		$594K Sell
14,800
-5,000
-25% -$188K ﹤0.01% 3515
2025
Q2 		$659K Buy
19,800
+3,500
+21% +$106K ﹤0.01% 3153
2025
Q1 		$478K Buy
16,300
+16,200
+16,200% +$537K ﹤0.01% 3137
2024
Q4 		$3.29K Sell
100
-4,500
-98% -$211K ﹤0.01% 6586
2024
Q3 		$204K Sell
4,600
-7,500
-62% -$341K ﹤0.01% 3592
2024
Q2 		$522K Sell
12,100
-31,300
-72% -$1.13M ﹤0.01% 2523
2024
Q1 		$1.27M Buy
43,400
+41,500
+2,184% +$1.11M ﹤0.01% 1875
2023
Q4 		$42.3K Sell
1,900
-8,100
-81% -$182K ﹤0.01% 5197
2023
Q3 		$248K Buy
10,000
+9,900
+9,900% +$262K ﹤0.01% 3622
2023
Q2 		$2.83K Sell
100
-4,000
-98% -$99.5K ﹤0.01% 6959
2023
Q1 		$94.2K Sell
4,100
-22,600
-85% -$600K ﹤0.01% 4352
2022
Q4 		$750K Buy
26,700
+700
+3% +$19.7K ﹤0.01% 2676
2022
Q3 		$735K Buy
26,000
+23,000
+767% +$617K ﹤0.01% 2875
2022
Q2 		$67K Sell
3,000
-51,400
-94% -$1.16M ﹤0.01% 5315
2022
Q1 		$1.58M Buy
54,400
+54,200
+27,100% +$1.66M ﹤0.01% 2632
2021
Q4 		$7K Sell
200
-10,000
-98% -$403K ﹤0.01% 7496
2021
Q3 		$471K Sell
10,200
-29,000
-74% -$1.4M ﹤0.01% 4254
2021
Q2 		$2.16M Buy
39,200
+20,000
+104% +$1.12M ﹤0.01% 2566
2021
Q1 		$991K Buy
19,200
+3,800
+25% +$188K ﹤0.01% 3239
2020
Q4 		$667K Sell
15,400
-19,200
-55% -$759K ﹤0.01% 3027
2020
Q3 		$1.21M Sell
34,600
-21,800
-39% -$956K ﹤0.01% 2025
2020
Q2 		$3.02M Sell
56,400
-2,500
-4% -$116K 0.01% 1167
2020
Q1 		$2.09M Buy
58,900
+23,300
+65% +$1.08M 0.02% 1013
2019
Q4 		$1.7M Buy
35,600
+27,600
+345% +$1.04M 0.01% 1418
2019
Q3 		$259K Hold
8,000
– – ﹤0.01% 2894
2019
Q2 		$399K Buy
8,000
+7,300
+1,043% +$390K ﹤0.01% 2337
2019
Q1 		$47K Sell
700
-38,900
-98% -$2.27M ﹤0.01% 3594
2018
Q4 		$1.83M Buy
39,600
+28,400
+254% +$1.75M 0.02% 1102
2018
Q3 		$864K Sell
11,200
-29,500
-72% -$2.37M 0.01% 1818
2018
Q2 		$3.43M Buy
40,700
+35,200
+640% +$3.07M 0.03% 749
2018
Q1 		$450K Sell
5,500
-10,300
-65% -$796K ﹤0.01% 2141
2017
Q4 		$903K Buy
15,800
+12,400
+365% +$780K 0.01% 1794
2017
Q3 		$227K Buy
3,400
+1,200
+55% +$72.1K ﹤0.01% 2678
2017
Q2 		$113K Sell
2,200
-1,200
-35% -$61.3K ﹤0.01% 3034
2017
Q1 		$199K Sell
3,400
-2,000
-37% -$95.9K ﹤0.01% 2523
2016
Q4 		$225K Sell
5,400
-9,100
-63% -$477K ﹤0.01% 2339
2016
Q3 		$766K Buy
14,500
+600
+4% +$26.1K 0.01% 1471
2016
Q2 		$582K Sell
13,900
-12,000
-46% -$593K 0.01% 1621
2016
Q1 		$1.05M Buy
25,900
+22,400
+640% +$958K 0.01% 1138
2015
Q4 		$227K Sell
3,500
-9,600
-73% -$630K ﹤0.01% 2408
2015
Q3 		$925K Buy
13,100
+4,100
+46% +$401K 0.01% 1302
2015
Q2 		$1M Sell
9,000
-1,400
-13% -$151K 0.01% 1203
2015
Q1 		$981K Sell
10,400
-1,500
-13% -$168K 0.02% 1101
2014
Q4 		$1.33M Buy
11,900
+3,300
+38% +$295K 0.02% 878
2014
Q3 		$528K Buy
8,600
+7,100
+473% +$306K 0.01% 1580
2014
Q2 		$69K Buy
+1,500
New +$61.1K ﹤0.01% 3310

Other funds holding AGIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Group One Trading's AGIO Position: Q1 2026 in Review

Group One Trading increased its Agios Pharmaceuticals (AGIO) stake by 4% in Q1 2026, buying an estimated $189K and bringing the position to 173,279 shares worth $5.86M. The position accounts for 0.01% of the portfolio, ranked #1175.

Group One Trading first reported a position in AGIO in Q4 2014 and has held it in 34 quarters since. 232 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Group One Trading held 173,279 shares of Agios Pharmaceuticals worth $5.86M as of Q1 2026.
  • Group One Trading bought 6,665 Agios Pharmaceuticals shares in Q1 2026, an estimated $189K.
  • Agios Pharmaceuticals made up 0.01% of Group One Trading's portfolio in Q1 2026, its #1175 holding.
  • Group One Trading first reported a position in Agios Pharmaceuticals in Q4 2014 and has held it in 34 quarters since.
  • 232 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.